| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 25, 2025Virtual Press Office and PR Newswire: General Trade show news
Omny-IRE data demonstrated the investigational OMNYPULSE™ Platform achieved 100% acute success and 84.5% pulmonary vein isolation (PVI) durability at three months, with promising safety...
-
Apr 25, 2025Virtual Press Office and PR Newswire: General Trade show news
Presentations to highlight efficacy, durability, and safety of Nanoscope's optogenetic therapy platforms DALLAS, April 25, 2025 /PRNewswire/ -- Nanoscope Therapeutics Inc., a biotech company...
-
Apr 25, 2025Virtual Press Office and PR Newswire: General Trade show news
- Renibus recently completed enrollment in a Phase 3 pivotal trial PROTECT to reduce the risk of post-operative complications and improve outcomes following cardiac surgery - SOUTHLAKE, Texas,...
-
Apr 25, 2025VPO Exhibitor
Colossal launches the 2025 competition that has tattooed storytellers nationwide putting their body art in the spotlight for a shot at ink immortality. PHOENIX, April 28, 2025 /PRNewswire/ --...
-
Apr 25, 2025Virtual Press Office and PR Newswire: General Trade show news
Innovations in liquid biopsy technology demonstrate a more accurate method to infer in-tissue copy number from ctDNA, detection of a novel non-tumor derived pseudogene of GNA11, and development of...
